Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration - PubMed (original) (raw)
Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration
Robert E Drolet et al. Neurotoxicology. 2004 Sep.
Abstract
The functional role of alpha-synuclein in the pathogenesis of Parkinson's disease (PD) is not fully understood. Systemic exposure of alpha-synuclein-deficient mice to neurotoxins provides a direct approach to evaluate how alpha-synuclein may mediate cell death in a common murine model of PD. To this end, wild-type and homozygous alpha-synuclein knock-out mice were treated with sub-chronic and prolonged, chronic exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In the sub-chronic model, wild-type and alpha-synuclein knock-out mice were treated for five consecutive days with MPTP (1-25 mg/kg, s.c.) or vehicle, and sacrificed 3 days following the last injection. The prolonged, chronic model consisted of two injections of MPTP (1-20 mg/kg, s.c.) per week for 5 weeks, with co-administration of probenecid (250 mg/kg, i.p.), and animals were sacrificed 3 weeks following the last injection. Sub-chronic administration of MPTP caused a dramatic, dose-dependent decrease in striatal dopamine (DA) concentrations, while an attenuated response was observed in alpha-synuclein knock-out mice. Similarly, prolonged, chronic administration of MPTP produced a dose-dependent decrease in striatal DA concentrations, and a corresponding loss of striatal vesicular monoamine transporter (VMAT-2) protein in wild-type mice. However, mice lacking alpha-synuclein had an attenuated loss of striatal DA concentrations, while no loss of striatal VMAT-2 protein was observed. Both sub-chronic and prolonged, chronic administration of MPTP caused an increase in the 3,4-dihydroxyphenylacetic acid (DOPAC) to DA ratio in wild-type mice, but not in mice lacking alpha-synuclein. Despite attenuated toxicity, elevated lactate concentrations were observed in alpha-synuclein knock-out mice following prolonged, chronic MPTP administration. The results of this study provide evidence that alpha-synuclein null mice have an attenuated response to the toxic effects of MPTP exposure, even over prolonged periods of time and that the biochemical sequela of a protracted insult to nigrostriatal DA neurons are distinct between mice with and without alpha-synuclein expression.
Similar articles
- Selective alterations of gene expression in mice induced by MPTP.
Xu Z, Cawthon D, McCastlain KA, Slikker W Jr, Ali SF. Xu Z, et al. Synapse. 2005 Jan;55(1):45-51. doi: 10.1002/syn.20089. Synapse. 2005. PMID: 15499605 - Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T. D'Astous M, et al. Synapse. 2003 Jan;47(1):10-4. doi: 10.1002/syn.10145. Synapse. 2003. PMID: 12422368 - [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K, Kondo T, Narabayashi H. Nishi K, et al. No To Shinkei. 1987 Jul;39(7):663-72. No To Shinkei. 1987. PMID: 3314916 Review. Japanese. - alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Sidhu A, Wersinger C, Vernier P. Sidhu A, et al. FEBS Lett. 2004 May 7;565(1-3):1-5. doi: 10.1016/j.febslet.2004.03.063. FEBS Lett. 2004. PMID: 15135042 Review.
Cited by
- A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
Chen L, Xie Z, Turkson S, Zhuang X. Chen L, et al. J Neurosci. 2015 Jan 21;35(3):890-905. doi: 10.1523/JNEUROSCI.0089-14.2015. J Neurosci. 2015. PMID: 25609609 Free PMC article. - Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.
St-Amour I, Bousquet M, Paré I, Drouin-Ouellet J, Cicchetti F, Bazin R, Calon F. St-Amour I, et al. J Neuroinflammation. 2012 Oct 9;9:234. doi: 10.1186/1742-2094-9-234. J Neuroinflammation. 2012. PMID: 23046563 Free PMC article. - Construct, Face, and Predictive Validity of Parkinson's Disease Rodent Models.
Guimarães RP, Resende MCS, Tavares MM, Belardinelli de Azevedo C, Ruiz MCM, Mortari MR. Guimarães RP, et al. Int J Mol Sci. 2024 Aug 17;25(16):8971. doi: 10.3390/ijms25168971. Int J Mol Sci. 2024. PMID: 39201659 Free PMC article. Review. - Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson's disease.
Kumar A, Ganini D, Mason RP. Kumar A, et al. Mol Neurodegener. 2016 Nov 24;11(1):70. doi: 10.1186/s13024-016-0135-y. Mol Neurodegener. 2016. PMID: 27884192 Free PMC article. - Adult neurogenesis in Parkinson's disease.
Marxreiter F, Regensburger M, Winkler J. Marxreiter F, et al. Cell Mol Life Sci. 2013 Feb;70(3):459-73. doi: 10.1007/s00018-012-1062-x. Epub 2012 Jul 6. Cell Mol Life Sci. 2013. PMID: 22766974 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources